Cardiovascular disease: An emerging role for RAS?

renin–angiotensin system (RAS), such as angiotensin-converting enzyme (ACE) inhibitors and AT1 receptor antagonists, are widely used to lower blood pressure. They have also been shown to decrease atherosclerosis but the mechanism of action is not well understood. Daugherty and colleagues now show that inhibiting renin — and therefore all downstream… CONTINUE READING